Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury

Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury

Myocardial ischemia-reperfusion injury increases myocardial microvascular permeability, leading to enhanced microvascular filtration and interstitial fluid accumulation that is associated with greater microvascular obstruction and inadequate myocardial perfusion. A burst of reactive oxygen species a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dmitry L. Sonin, Mikhail S. Medved, Asker Y. Khapchaev, Maria V. Sidorova, Marina E. Palkeeva, Olga A. Kazakova, Garry V. Papayan, Daniil A. Mochalov, Sarkis M. Minasyan, Ilya E. Anufriev, Daria V. Mukhametdinova, Natalia M. Paramonova, Ksenia M. Balabanova, Anastasia S. Lopatina, Ilia V. Aleksandrov, Natalya Yu. Semenova, Anna A. Kordyukova, Kirill V. Zaichenko, Vladimir P. Shirinsky, Michael M. Galagudza
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Current Issues in Molecular Biology
Subjects:	myosin light chain kinase peptide inhibitor PIK7 ischemic and reperfusion injury myocardial infarction no-reflow microvascular hyperpermeability
Online Access:	https://www.mdpi.com/1467-3045/47/1/33
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Relationship Of PIK R And PIK M Activities And Attitudes Towards Reproductive Health Behaviors In Adolescents In Pulo Lor Jombang
by: Nur Laila Faizah, et al.
Published: (2024-12-01)

Uncovering somatic mosaic variants of PIK3CA-related overgrowth disorders – three cases with different clinical presentations
by: M. Tooming, et al.
Published: (2025-01-01)

Dengue haemorrhagic fever: a job done via exosomes?
by: Ritu Mishra, et al.
Published: (2019-01-01)

Pharmacological correction of no-reflow phenomenon in myocardial infarction treatment
by: T. Yu. Mamonova, et al.
Published: (2009-04-01)

Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA-related overgrowth spectrum or Proteus syndrome
by: Whitney Eng, et al.
Published: (2025-07-01)

Early Postischemic Cerebral Circulatory Disorders and Their Correction with Perftoran
by: V. V. Aleksandrin, et al.
Published: (2006-06-01)

The no-reflow phenomenon: current treatment and prevention strategies
by: S. V. Dil, et al.
Published: (2025-04-01)

The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
by: Young-Bin Cho, et al.
Published: (2025-03-01)

Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
by: V. V. Ryabov, et al.
Published: (2023-09-01)

Mutations of the PIK3CA gene in patients with breast cancer in the Krasnoyarsk region
by: A. V. Zyuzyukina, et al.
Published: (2024-07-01)

CORONARY MICROVASCULAR OBSTRUCTION PHENOMENON AFTER ENDOVASCULAR RECANALIZATION IN PATIENTS WITH CHRONIC CORONARY OCCLUSIONS
by: N. A. Yaitsky, et al.
Published: (2018-01-01)

Predictive and prognostic features of early and locally advanced <i>PIK3CA</i>-mutated luminal HER2-negative breast cancer
by: A. I. Stukan, et al.
Published: (2024-01-01)

No-reflow phenomenon and reperfusion injury. Mechanisms and treatment
by: M. Yu. Gilyarov, et al.
Published: (2022-03-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

PIK3CA mutations in breast cancer with low HER2 / neu expression
by: I. A. Pavlenko, et al.
Published: (2022-12-01)

Синдром коронарной микрососудистой обструкции при чрескожных коронарных вмешательствах у пациентов с инфарктом миокарда: комплексный подход к профилактике и лечению
by: А.А. Фролов, et al.
Published: (2024-11-01)

<i>Orthoflavivirus omskense</i> NS1 Protein Induces Microvascular Endothelial Permeability In Vitro
by: Bogdana I. Kravchuk, et al.
Published: (2025-06-01)

Prognostic value of no-reflow phenomenon in myocardial infarction: the role of the severity of ischemic damage
by: A. A. Frolov, et al.
Published: (2025-01-01)

The role of PIK3CA mutations in the development of breast cancer (a literature review)
by: A. O. Pryvalova, et al.
Published: (2020-08-01)

Intracoronary epinephrine and verapamil in the refractory no-reflow phenomenon in patients with acute myocardial infarction
by: S. V. Dil, et al.
Published: (2022-01-01)

PRIMARY ANGIOPLASTICS AND PHARMACOINVASIVE REPERFUSION IN MYOCARDIAL INFARCTION: IMPACT ON CLINICAL OUTCOMES AND NO-REFLOW PHENOMENON
by: E. V. Vyshlov, et al.
Published: (2015-02-01)

Multimodal imaging biomarkers of subretinal hyperreflective material accumulation in central serous chorioretinopathy
by: Jiaxin Pu, et al.
Published: (2025-06-01)

PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer
by: Eduardo Terán, et al.
Published: (2024-09-01)

STUDY OF PHENIBUT ANTIEDEMIC ACTION AND NEW GABA DERIVATIVES
by: T. N. Scherbakova, et al.
Published: (2015-09-01)

Interventional Traps in Ectatic Coronary Arteries: A Case Report
by: Krešimir Gabaldo, et al.
Published: (2024-01-01)

Association of PIK3CA somatic mutations with clinicopathological parameters in breast cancer
by: Gizem Teoman, et al.
Published: (2024-12-01)

PIK3R1 mutations in individuals with insulin resistance or growth retardation: Case series and in silico functional analysis
by: Tomofumi Takayoshi, et al.
Published: (2025-08-01)

Myocardial ischemia – reperfusion injury
by: S. V. Salo, et al.
Published: (2023-10-01)

Widefield indocyanine green angiography evaluating choroidal vein drainage pattern and choroidal vein alterations in acute and chronic central serous chorioretinopathy
by: Xinlei Hao, et al.
Published: (2024-12-01)

NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01)

Paradoxical dominant negative activity of an immunodeficiency-associated activating PIK3R1 variant
by: Patsy R Tomlinson, et al.
Published: (2025-01-01)

Knockdown of PIK3R6 impedes the onset and advancement of clear cell renal cell carcinoma
by: Jia Yang, et al.
Published: (2024-12-01)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2020-01-01)

The Impact of Baseplate Bow on Vacuum Reflow Soldering
by: 曾雄, et al.
Published: (2011-01-01)

Vapour phase reflow soldering with vertical assembly stacking to improve productivity
by: Gergő Havellant, et al.
Published: (2025-03-01)

PIK3CA gene mutation status associated with poor prognosis of breast cancer: a retrospective cohort study
by: Min Yan, et al.
Published: (2025-02-01)

Thrombolysis for Prevention of Cerebral No-Reflow After Cardiopulmonary Resuscitation
by: K. -A. Hossmann, et al.
Published: (2009-04-01)

«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01)

Oncogenic activation of PIK3CA in cancers: Emerging targeted therapies in precision oncology
by: Yuxiang Wang, et al.
Published: (2025-03-01)

FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A‐Demethylation of PIK3R3 mRNA
by: Bingxin Chen, et al.
Published: (2024-12-01)